GPRC5A and neoplasm: We isolated Sca-1+Abcg1+cells from Gprc5a-KO mice and SPA+ABCG1+ cells from tumor samples from patients with lung cancer, respectively (Fig. 5l) and injected these cells into NOD/SCID mice via the tail vein to evaluate the tumor initiation capacity of this subset.